SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:lup.lub.lu.se:ae29303c-13e7-4e07-86ba-c6e70216e05e"
 

Sökning: id:"swepub:oai:lup.lub.lu.se:ae29303c-13e7-4e07-86ba-c6e70216e05e" > Proteomic Determina...

Proteomic Determinants of Variation in Cholesterol Efflux : Observations from the Dallas Heart Study

Gangwar, Anamika (författare)
University of Texas Southwestern Medical Center
Deodhar, Sneha S. (författare)
University of Texas Southwestern Medical Center
Saldanha, Suzanne (författare)
University of Texas Southwestern Medical Center
visa fler...
Melander, Olle (författare)
Lund University,Lunds universitet,Kardiovaskulär forskning - hypertoni,Forskargrupper vid Lunds universitet,Cardiovascular Research - Hypertension,Lund University Research Groups
Abbasi, Fahim (författare)
Stanford University School of Medicine
Pearce, Ryan W. (författare)
Quest Diagnostics Cardiometabolic Center of Excellence
Collier, Timothy S. (författare)
Quest Diagnostics Cardiometabolic Center of Excellence
McPhaul, Michael J. (författare)
Quest Diagnostics
Furtado, Jeremy D. (författare)
Biogen, Inc.
Sacks, Frank M. (författare)
Harvard University
Merrill, Nathaniel J. (författare)
Pacific Northwest National Laboratory
McDermott, Jason E. (författare)
Pacific Northwest National Laboratory
Melchior, John T. (författare)
Oregon Health & Science University,University of Cincinnati
Rohatgi, Anand (författare)
University of Texas Southwestern Medical Center
visa färre...
 (creator_code:org_t)
2023
2023
Engelska.
Ingår i: International Journal of Molecular Sciences. - 1661-6596. ; 24:21
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • High-density lipoproteins (HDLs) are promising targets for predicting and treating atherosclerotic cardiovascular disease (ASCVD), as they mediate removal of excess cholesterol from lipid-laden macrophages that accumulate in the vasculature. This functional property of HDLs, termed cholesterol efflux capacity (CEC), is inversely associated with ASCVD. HDLs are compositionally diverse, associating with >250 different proteins, but their relative contribution to CEC remains poorly understood. Our goal was to identify and define key HDL-associated proteins that modulate CEC in humans. The proteomic signature of plasma HDL was quantified in 36 individuals in the multi-ethnic population-based Dallas Heart Study (DHS) cohort that exhibited persistent extremely high (>=90th%) or extremely low CEC (<=10th%) over 15 years. Levels of apolipoprotein (Apo)A-I associated ApoC-II, ApoC-III, and ApoA-IV were differentially correlated with CEC in high (r = 0.49, 0.41, and −0.21 respectively) and low (r = −0.46, −0.41, and 0.66 respectively) CEC groups (p for heterogeneity (pHet) = 0.03, 0.04, and 0.003 respectively). Further, we observed that levels of ApoA-I with ApoC-III, complement C3 (CO3), ApoE, and plasminogen (PLMG) were inversely associated with CEC in individuals within the low CEC group (r = −0.11 to −0.25 for subspecies with these proteins vs. r = 0.58 to 0.65 for subspecies lacking these proteins; p < 0.05 for heterogeneity). These findings suggest that enrichment of specific proteins on HDLs and, thus, different subspecies of HDLs, differentially modulate the removal of cholesterol from the vasculature.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Läkemedelskemi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Medicinal Chemistry (hsv//eng)

Nyckelord

apolipoprotein
atherosclerotic cardiovascular disease
cholesterol efflux capacity
high-density lipoproteins (HDLs)
proteomics

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy